DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Laurian Y, Goudemand J, Negrier C. et al.
Use of recombinant activated factor VII as first-line therapy for bleeding episodes in haemophiliacs with factor VIII or IX inhibitors (NOSEPAC study).
Blood Coagul Fibrinolysis 1998;
09 Suppl: (Suppl. 01) S155-6.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.